Autoimmunity in Myasthenia Gravis

April 1965
British Medical Journal;4/3/1965, Vol. 1 Issue 5439, p879
Academic Journal
No abstract available.


Related Articles

  • High dose cyclophosphamide for severe refractory myasthenia gravis. Gladstone, D. E.; Brannagan III, T. H.; Schwartzman, R. J.; Prestrud, A. A.; Brodsky, I.; Brannagan, T H 3rd // Journal of Neurology, Neurosurgery & Psychiatry;May2004, Vol. 75 Issue 5, p789 

    Presents a letter to the editor about myasthenia gravis an autoimmune disease.

  • Prednisolone.  // Reactions Weekly;2/25/2012, Issue 1390, p34 

    The article describes the case of an adolescent female with autoimmune myasthenia gravis who developed bipolar affective disorder while receiving pyridostigmine.

  • Myasthenic crisis after the cessation of FK506 in a patient with myasthenia gravis. Konishi, Tetsuro; Sanada, Mitsuru; Takehana, Kazuya // Journal of Neurology;Sep2004, Vol. 251 Issue 9, p1154 

    Presents a letter to the editor about myasthenia gravis, a T-cell dependent chronic autoimmune disorder.

  • BOX 7-4 MYASTHENIA GRAVIS. Scanlon, Valerie C.; Sanders, Tina // Essentials of Anatomy & Physiology;Jan2007, p148 

    Information on myasthenia gravis from Chapter 7 of the book "Essentials of Anatomy & Physiology" is presented. It is a n autoimmune disorder which is characterized by extreme muscle fatigue. The symptoms of the disease are described. Anticholinesterase medications are used in the treatment of...

  • Myasthenia Gravis.  // New Harvard Guide to Women's Health;2004, p397 

    Presents a comprehensive women's health guide to myasthenia gravis, a rare autoimmune disorder characterized by episodes of muscular weakness. Pathophysiology; Epidemiology and symptoms; Medical tests for myasthenia gravis; Treatment options.

  • Myasthenia Gravis and Auto-immune Disease. Piemme, Thomas E. // Annals of Internal Medicine;Jan64, Vol. 60 Issue 1, p130 

    Presents a review of literature about myasthenia gravis and autoimmune disease and a case report of the coexistence of myasthenia and systemic lupus erythematosus. Clinical characteristics of myasthenia; Patient case background; Treatment.

  • Myasthenia gravis. Spillane, J.; Higham, E.; Kullmann, D. M. // BMJ: British Medical Journal;1/19/2013, Vol. 346 Issue 7891, p36 

    The article discusses obstacles in diagnosing myasthenia gravis, an autoimmune disorder of neuromuscular transmission characterized by fatigable muscle weakness. It states that the unpredictable nature of the symptoms can make myasthenia gravis difficult to diagnose. It s mentioned that even if...

  • Penicillamine induced myasthenia reactivated by gold. Moore, A.P.; Williams, A.C.; Hillenbrand, P. // British Medical Journal (Clinical Research Edition);1/21/1984, Vol. 288 Issue 6412, p192 

    Presents a case report of a reactivated penicillamine induced myasthenia gravis by gold. Clinical feature of the patient; Mechanism of action of penicillamine in inducing autoimmune disorders; Caution in prescribing gold to patient with penicillamine induced myasthenia.

  • Treat myasthenia gravis with individualized doses of acetylcholinesterase inhibitors and immunomodulators.  // Drugs & Therapy Perspectives;Jul2011, Vol. 27 Issue 7, p18 

    Myasthenia gravis is an autoimmune condition that results in abnormal neuromuscular transmission and muscle weakness. Current pharmacological treatment options include acetylcholinesterase inhibitors and long- and shortterm immunotherapy.

  • Edrophonium/pyridostigmine.  // Reactions Weekly;12/17/2011, Issue 1382, p18 

    The article describes the case of a 27-year-old woman, with autoimmune myasthenia gravis, who developed hypersalivation and fasciculations during treatment with edrophonium and pyridostigmine.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics